Engineering Macrophages for Cancer Immunotherapy: CAR-M & Beyond
Time: 2:45 pm
day: Day 1 - Track B - Mid
Details:
- Reviewing clinical progress with CAR-M cell therapy
- Introducing a novel in vivo mRNA CAR-M platform
- Beyond CAR – other engineering strategies for cancer and immunology
